Prospector
Profile
07.1054
|
| |
| Globetech Environmental, Inc. |
NAICS |
325612 |
| 300 South Fourth Street, Suite 700
Las Vegas, NV 89101 |
Description |
Disinfectants Mfg. |
| (403) 261-2929 |
Employees |
0 |
| http://www.globetechenv.com/ |
Revenue |
(mil) |
0.3790 |
| |
Income |
(mil) |
-1.5100 |
| |
Assets |
(mil) |
1.5420 |
| |
Liability |
(mil) |
2.5660 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
Child Van Wagoner & Bradshaw PLLC raised doubts on the ability of Globetech Environmental, Inc. to continue as a going concern after auditing its financial statements. The Company has incurred net losses of approximately $4,448,330 since inception, has a liquidity problem, and requires additional financing in order to finance its business activities on an ongoing basis.
|
| |
|
Intellectual Property:
In connection with the acquisition of Logmed Technologie GmbH, the Company acquired a portfolio of 26 patents covering the principal proprietary technologies incorporated into the Logmed units. The Company intends to vigorously defend its patents and to continuously seek new and additional patents as necessary to protect its rights in future technological advances in its products. [SEC Filing 10-KSB 06-25-07]
|
| |
|
Description:
The Company engages in the marketing, sale, and leasing of proprietary medical waste disinfection/sterilization units and operation of a contract medical waste treatment facility in Wittenberg, Germany.
|
| |
|
Officers:
Donald Sampson (Pres., CEO & Dir.); Theodor Hennig (CFO & Dir.); Donald Getty (Chair); Hans-Eberhardt Frenzel (Dir.)
|
| |
|
Auditor:
Child Van Wagoner & Bradshaw PLLC
|
| |
|
Securities:
Common Stock-Symbol GENV.PK; Other OTC;
67,354,007 common shares outstanding as of May 31, 2007.
|
| |
| |
| |
| return to main page |
